Transcend Therapeutics, A Mental Health-Focused Biotechnology Company, Announces Series A Funding Round Of $40 Million Led By Alpha Wave Global And Integrated Investment Partners
Round Type
Series A
New YorkBiotechnologyHealth CareMedicalTherapeuticsInvestors
Description
Transcend Therapeutics, a biotechnology company that develops medicines to treat neuropsychiatric diseases, including post-traumatic stress disorder (PTSD), today announced that it closed its Series A funding round of $40 million. Led by Alpha Wave Global and Integrated Investment Partners, this funding round will enable Transcend to launch multiple clinical trials, including a phase II study, with its next-generation psychoactive compound. Transcend has raised nearly $42 million to date.
Quick answer
Transcend Therapeutics raised an undisclosed amount in a Series A round, dated February 23, 2023. Investors: Integrated Investment Partners and Alpha Wave Global. Transcend Therapeutics is based in New York, United States.
- How much did Transcend Therapeutics raise?
- Transcend Therapeutics raised an undisclosed amount in a Series A round on February 23, 2023.
- Who invested in Transcend Therapeutics?
- Integrated Investment Partners and Alpha Wave Global are named as investors in this round.
- What does Transcend Therapeutics do?
- Transcend Therapeutics discovers, develops, and delivers next-generation psychoactive medicines to work toward a world in which people no longer suffer from neuropsychiatric disease.
- Where is Transcend Therapeutics based and how big is it?
- Transcend Therapeutics is based in New York, United States.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Transcend Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Current Surgical raised $3.2M (Seed) on February 21, 2023.
- Grey Wolf Therapeutics raised $49M (Funding Round) on January 27, 2023.
- HBM Alpha Therapeutics raised an undisclosed amount (Seed) on January 26, 2023.
- OXOS Medical raised $23M (Series A) on April 5, 2023.
- Wilson Wolf Manufacturing raised an undisclosed amount on April 3, 2023.
- PureIMS raised an undisclosed amount on April 3, 2023.
Who to call at Transcend Therapeutics, and when
A new round usually means Transcend Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Transcend Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Transcend Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Transcend Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Transcend Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansTranscend Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.